View More Recent Stories
-
Alliqua BioMedical, Inc. Reports Second Quarter Financial Results
-
Alliqua BioMedical, Inc. Reports Second Quarter Financial Results
-
Alliqua BioMedical, Inc. to Ring the Nasdaq Stock Market Opening Bell on July 6th
-
Alliqua BioMedical, Inc. to Ring the Nasdaq Stock Market Opening Bell on July 6th
-
Alliqua BioMedical, Inc. Announces the Publication of Results From a Biovance(R) Use Registry Study in WOUNDS
-
Alliqua BioMedical, Inc. Announces the Publication of Results From a Biovance(R) Use Registry Study in WOUNDS
-
Alliqua BioMedical, Inc. Appoints Nino Pionati as Chief Strategy and Marketing Officer
-
Alliqua BioMedical, Inc. Appoints Nino Pionati as Chief Strategy and Marketing Officer
-
Alliqua BioMedical, Inc. Announces Closing of Celleration, Inc. Acquisition
-
Alliqua BioMedical, Inc. Announces Closing of Celleration, Inc. Acquisition
-
Alliqua BioMedical, Inc. Reports First Quarter Financial Results
-
Alliqua BioMedical, Inc. Reports First Quarter Financial Results
-
Alliqua Biomedical Announces Expansion to Its Exclusive Licensing Agreement with Celgene Cellular Therapeutics
-
Alliqua BioMedical Presents at the Spring 2015 Symposium on Advanced Wound Care
-
Alliqua BioMedical, Inc. Announces Closing of $34.5 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
-
Alliqua BioMedical, Inc. Announces Closing of $34.5 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
-
Alliqua BioMedical, Inc. Announces Pricing of Public Offering of Common Stock
-
Alliqua BioMedical, Inc. Announces Pricing of Public Offering of Common Stock
-
Alliqua BioMedical, Inc. Announces Proposed Public Offering of Common Stock
-
Alliqua BioMedical, Inc. Announces Proposed Public Offering of Common Stock
-
Alliqua BioMedical, Inc. Announces Preliminary First Quarter 2015 Revenue Results & Updates Fiscal Year 2015 Revenue Guidance
-
Alliqua BioMedical, Inc. Announces Preliminary First Quarter 2015 Revenue Results & Updates Fiscal Year 2015 Revenue Guidance
-
Alliqua BioMedical, Inc. Receives Coverage From Medicare Administrative Contractor (MAC) for Biovance(R)
-
Alliqua BioMedical, Inc. Receives Coverage From Medicare Administrative Contractor (MAC) for Biovance(R)
-
Alliqua BioMedical, Inc. to Acquire Celleration, Inc.
-
Alliqua Biomedical, Inc. Reports Second Quarter 2014 Financial Results
-
Alliqua BioMedical Added to the Russell Microcap(R) Index
-
Alliqua Reincorporates in State of Delaware, De-Staggers Board and Changes Name to Alliqua BioMedical
-
Alliqua to Launch Biovance(R) Human Amniotic Membrane Allograft Product Licensed From Celgene
-
Alliqua Biomedical Announces New Data on sorbion(R) Wound Care Dressings to be Presented at the Spring 2014 SAWC Meeting
-
Alliqua Raises $20.3 Million in Private Placement of Equity and Exercise of Warrants
-
Alliqua to Present at 26th Annual ROTH Conference on March 10

